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Abstract
Background: Intercellular adhesion molecule 1 (ICAM-1) is an immunoglobulin-like cell adhesion
molecule expressed on the surface of multiple cell types, including airway epithelial cells. It has been
documented that cross-linking ICAM-1 on the surface of leukocytes results in changes in cellular
function through outside-inside signaling; however, the effect of cross-linking ICAM-1 on the
surface of airway epithelial cells is currently unknown. The objective of this study was to investigate
whether or not cross-linking ICAM-1 on the surface of airway epithelial cells phosphorylated MAP
kinases or stimulated chemokine expression and secretion.
Methods: The human lung adenocarcinoma (A549) cells and primary cultures of normal human
bronchial epithelial (NHBE) cells were used in these studies. To increase ICAM-1 surface
expression, cultures were stimulated with TNFα to enhance ICAM-1 surface expression. Following
ICAM-1 upregulation, ICAM-1 was ligated with a murine anti-human ICAM-1 antibody and
subsequently cross-linked with a secondary antibody (anti-mouse IgG(ab')2) in the presence or
absence of the MAP kinase inhibitors. Following treatments, cultures were assessed for MAPK
activation and chemokine gene expression and secretion. Control cultures were treated with
murine IgG1 antibody or murine IgG1 antibody and anti-mouse IgG(ab')2 to illustrate specificity.
Data were analyzed for significance using a one-way analysis of variance (ANOVA) with Bonferroni
post-test correction for multiple comparisons, and relative gene expression was analyzed using the
2-∆∆CT method.
Results: ICAM-1 cross-linking selectively phosphorylated both ERK and JNK MAP kinases as
detected by western blot analysis. In addition, cross-linking resulted in differential regulation of
chemokine expression. Specifically, IL-8 mRNA and protein secretion was not altered by ICAM-1
cross-linking, in contrast, RANTES mRNA and protein secretion was induced in both epithelial
cultures. These events were specifically inhibited by the ERK inhibitor PD98059. Data indicates that
ICAM-1 cross-linking stimulates a synergistic increase in TNFα-mediated RANTES production
involving activation of ERK in airway epithelial cells.
Conclusion:  Results demonstrate that cytokine induced ICAM-1 on the surface of airway
epithelial cells induce outside-inside signaling through cross-linking ICAM-1, selectively altering
intracellular pathways and cytokine production. These results suggest that ICAM-1 cross-linking
can contribute to inflammation in the lung via production of the chemokine RANTES.
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Background
The airway epithelium lining the airways functions as a
protective barrier from inhaled particulates and aerosols
from the external environment. Additionally, it regulates
leukocyte trafficking into the airway lumen through adhe-
sion molecules and cytokine responses. Therefore, in the
inflamed airway, epithelial cells can function as both ''tar-
get'' and ''effector'' cells. As target cells, they are influenced
by exogenous inflammatory agents. As effector cells, they
produce and release inflammatory mediators. Many of
these cellular events are regulated by interactions through
adhesion molecules as well as soluble factors such as
chemokines.
Intercellular adhesion molecule-1 (ICAM-1) is a 95 kDa
surface glycoprotein [belonging to the immunoglobulin
supergene family] that has been detected on a variety of
cell types, including human airway epithelium [1]. ICAM-
1 is involved in cell-to-cell interactions and microbial
pathogenesis. ICAM-1 has also been suggested to partici-
pate in cell signaling through outside-inside signaling
events in several different cell types [2]. Interestingly, it
has not been determined whether ICAM-1 functions as a
signaling molecule to transmit biochemical signals in air-
way epithelial cells.
Previously [3], we have demonstrated that the cytokine
TNFα, upregulates both gene and surface expression of
ICAM-1 in airway epithelial cells in vitro. It has been well
documented that airway epithelial cells produce chemok-
ines, which are involved in airway inflammation [4-6].
Both RANTES (regulated on activation normal T cell
expressed and secreted) and interleukin-8 (IL-8) are
chemokines that are secreted by the epithelium and play
an important role in asthmatic airways through the
recruitment of inflammatory cells by functioning as
chemo-attractant [7-11]. High levels of RANTES and inter-
leukin-8 in nasal and bronchial mucosa contribute to the
massive recruitment of leukocytes enhancing inflamma-
tion in the airway.
One of the signaling pathways implicated in regulating
both IL-8 and RANTES expression is the mitogen-acti-
vated protein (MAP) kinase cascade [12,13]. Many extra-
cellular stimuli have been shown to elicit specific biologic
responses through activation of MAP kinases [14]. The
MAP kinase superfamily has been molecularly character-
ized into three groups which include: extracellular signal-
regulated kinase p42 p44 (ERK), p38 MAP kinase (HOG),
and JNK/SAPK (c-jun N-terminal kinase/stress activated
protein kinase). The MAP kinase cascade has been dem-
onstrated to play a central role in airway remodeling
[15,16] and plays an important role in the induction of
several chemokines through various environmental fac-
tors [17,18].
This study examined the effects of cross-linking ICAM-1
on outside-inside signaling in human airway epithelial
cells. Specifically, we investigated whether ligation of
ICAM-1 on airway epithelial cells resulted in activation of
ERK, p38 and JNK. Additionally, we examined whether
cross-linking ICAM-1 induced IL-8 and RANTES gene
expression and protein secretion through activation of
MAP kinases. Utilizing both a human lung adenocarci-
noma cell line (A549) and primary cultures of normal
human bronchial epithelial (NHBE) cells, data represent-
ing the normal airway epithelium did not respond to
ICAM-1 cross-linking. In contrast, cultures that were stim-
ulated by the cytokine TNFα to increase ICAM-1 surface
expression, resulted in selective activation of the MAP
kinases ERK and JNK. In addition, cross-linking ICAM-1
on cells pre-exposed to TNFα differentially stimulated IL-
8 and RANTES gene expression and secretion. Our results
suggest that cytokine induced ICAM-1 on the surface of
airway epithelial cells selectively activate both MAP
kinases and chemokines through ICAM-1 cross-linking.
Additionally, cross-linking ICAM-1 induced RANTES pro-
duction appears mediated through an ERK-dependent
pathway.
Materials and methods
Sources of reagents
All the reagents were purchased from Sigma Chemical Co.
(St. Louis, MO) unless otherwise stated. Human recom-
binant TNFα (hrTNFα; 0.015–150 ng/ml [Spec. Activity =
2.86 × 107 U/mg]) and RANTES sandwich ELISA kit were
purchased from R&D Systems (Mineapolis, MN). Ham's
F-12K medium, fetal bovine serum (FBS), penicillin and
streptomycin were purchased from GIBCO BRL (Rock-
ville, MD). Monoclonal antibody mouse anti-human
CD54 (Clone 6.5B5) was purchased from DAKO Corpo-
ration (Carpinteria, CA). Negative control monoclonal
antibody (IgG1) was purchased from Becton Dickinson
(San Jose, CA). Polyclonal antibody goat anti-mouse IgG
Fc, γ specific was purchased from ICN Biomedical (Costa
Mesa, CA). The selective MEK inhibitor PD98059 and the
JNK inhibitor (JNK inhibitor-1) was purchased from Cal-
biochem (La Jolla, CA).
Culture of cells
NHBE culture
Expansion, cryopreservation and culturing of NHBE cells
in an air-liquid interface system were performed as previ-
ously described [3]. Briefly, NHBE cells (Clonetics, San
Diego, CA) were seeded into vented T75 tissue culture
flasks (500 cells/cm2) until cells reached 75–80% conflu-
ence. Cultures were dissociated with trypsin/EDTA and
cultured in an air-liquid interface system initiated by seed-
ing NHBE cells (passage-2, 2 × 104 cells/cm2) onto Tran-
swell-clear culture inserts (24.5 mm, 0.45 mm pore size;
Costar, Cambridge, MA) that were thin-coated with rat tailRespiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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collagen, type I (Collaborative Res., Bedford, MA). Cells
were cultured submerged for the first 5–7 days. At that
time, the air-liquid interface was created by removing the
apical medium and feeding cells with medium on their
basal surface only. The apical surface of the cells was
exposed to a humidified 95% air/5% CO2 environment.
Medium beneath the cells was changed daily thereafter
[3]. Cells were cultured for an additional 14 days in air-
liquid interface, for a total of 21 days in culture.
A549 culture
The A549 tumor-cell line, initiated from a human alveolar
cell carcinoma (ATCC CCL-185, Rockville, MD) was cul-
tured in Ham's F-12K medium supplemented with 10%
FBS, penicillin (100 U/ml), and streptomycin (100 µg/
ml). Cells were grown at 37°C in a humidified atmos-
phere containing 5% CO2 on 6-well plastic culture plates.
Cultures were utilized upon reaching confluency.
Measurement of chemokine secretion
Concentrations of IL-8 and RANTES in the culture super-
natants were quantified by using a commercially available
sandwich ELISA kits (R&D Systems, Minneapolis, MN).
All samples were assayed in triplicate.
Western blot analysis of MAP kinases
Analysis of threonine and tyrosine phosphorylation of
MAP kinases were performed using an anti-phosphor-
ylated threonine and tyrosine p42/p44, JNK and p38 MAP
kinase antibodies (New England Bio Labs, Beverly, MA),
specific for active p42/p44, JNK and p38 MAP kinase. Fol-
lowing treatments, cells were lysed in lysis buffer (50 mM
HEPES, 150 mM NaCl, 1% Triton X-100, 1 mM AEBSF, 20
µg/ml aprotinin, and 20 µg/ml leupeptin) and clarified by
centrifugation at 13,000 rpm for 10 minutes. Harvested
protein concentrations were determined using the Brad-
ford dye-binding procedure (Bio-Rad Protein Assay; Bio-
Rad, Richmond, CA). Following quantification, samples
containing 25 µg of protein were separated by 12% SDS-
polyacrylamide gel electrophoresis, electrophoretically
transferred to a membrane, and incubated with specific
antibodies. Following antibody treatments, blots were
incubated with horseradish peroxidase (HRP)-conjugated
secondary antibody (Pierce Biotechnology, Rockford, IL).
Blots were then treated with SuperSignal West Dura
extended duration chemiluminescence substrate solution
(Pierce Biotechnology, Rockford, IL) and analyzed using a
Fluor-S Max2 (Bio-Rad, Richmond, CA) MultiImager sys-
tem and associated software. Blots were stripped and rep-
robed using phosphorylation-state independent
antibodies for p42/p44, JNK and p38 MAP kinase (New
England Bio Labs, Beverly, MA) to determine total MAP
kinase levels.
Measurement of chemokine mRNA by real time PCR
Total mRNA was harvested with the Absolutely RNA™ RT-
PCR Miniprep kit (Stratagene, La Jolla, CA) according to
the manufacturer's protocol. Chemokine gene expression
was quantified in a two-step reverse transcription-
polymerase chain reaction (RT-PCR). Complimentary
DNA was reverse transcribed from total RNA samples
(0.625 µg/50 µl) using random hexamers from the Taq-
Man RT reagents (Applied Biosystems, Foster City, CA).
PCR products were synthesized from cDNA (22.5 ng/20
µl) using the TaqMan universal PCR master mix and
Assays on Demand ™ gene expression reagents for human
RANTES and IL-8 (Assay ID:Hs00174575_m1 and Assay
ID: Hs00174103_m1, Applied Biosystems, Foster City,
CA). Measurements were done using the ABI Prism
7900HT sequence detection system according to the man-
ufacturer's protocol. As an endogenous control for these
PCR quantification studies, 18S ribosomal RNA gene
expression was measured using the TaqMan ribosomal
RNA control reagents (Applied Biosystems, Foster City,
CA). Results represent normalized IL-8 and RANTES
mRNA amounts relative to control cultures using the 2-
∆∆CT method [19]. Each experiment was repeated in tripli-
cate.
Stimulation and cross-linking of ICAM-1 on airway epithelial cultures
We have previously published that stimulation of airway
epithelial cells in vitro with TNF α enhances ICAM-1 sur-
face expression [3,20]. Therefore, to increase ICAM-1 sur-
face expression, all experimental cultures were stimulated
with 50 ng/ml TNF α for two hours followed by an incu-
bation in medium alone for 18 hours to increase ICAM-1
expression prior to cross-linking. To cross-link ICAM-1 on
the surface of both A549 and NHBE cells, cultures were
incubated with 15 ug/ml anti-ICAM-1 mAb at 37°C for 30
minutes. Following incubation, cultures were washed two
times with 0.1% FBS medium and subsequently incu-
bated with 50 ug/ml anti-mouse IgG F(ab')2. To demon-
strate specificity for ICAM-1 cross-linking, cultures were
exposed to the following conditions. Cultures were incu-
bated with 0.1% FBS medium alone, anti-mouse IgG
F(ab')2 alone, control anti-mouse IgG1 alone, control
anti-mouse IgG1 subsequently incubated with 50 ug/ml
anti-mouse IgG F(ab')2, or anti-VCAM-1 mAb subse-
quently incubated with 50 ug/ml anti-mouse IgG F(ab')2
to demonstrate that the response was specifically due to
crosslinking the ICAM-1 molecule on the surface of the
cells. None of the combinations of antibodies altered
either IL-8 or RANTES mRNA or protein secretion. This
method of cross-linking ICAM-1 on the surface of cells has
been widely used in multiple cell types [21-24].Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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Effect of cross-linking ICAM-1 on MAP kinase phosphorylation and 
chemokine gene expression and secretion
To investigate a potential role for cross-linking ICAM-1 in
stimulating phosphorylation of MAP kinases, ICAM-1 was
cross-linked for 5, 10, 15, and 30 minutes. Cells were then
rinsed twice in PBS, and total protein was harvested and
assayed for phosphorylation of MAP kinases by western
blot.
To investigate the role for cross-linking ICAM-1 in chem-
okine steady-state mRNA expression, ICAM-1 was cross-
linked for 1, 2, and 4 hours. Following cross-linking, cells
were rinsed in PBS and total RNA was harvested and
assayed by RT-PCR analysis. To investigate whether the
effect of cross-linking ICAM-1 stimulated chemokine
secretion, cells were cross-linked for ICAM-1 for 1, 2, 4, 6,
and 12 hours. Following cross-linking, cell supernatants
were collected and assayed for both RANTES and IL-8 by
ELISA.
To address the effect of the MAP kinase inhibitors on
ICAM-1 induced events, cells were pre-incubated for 30
minutes in the presence or absence of MAP kinase inhibi-
tors followed by cross-linking of ICAM-1 for 10 minutes
for ERK phosphorylation and 30 minutes for JNK activa-
tion. Cells were then rinsed twice in PBS, and samples
were harvested and assayed for phosphorylation of MAP
kinases by western blot. For chemokine gene and surface
expression, cells were pre-incubated for 30 minutes with
MAP kinase inhibitors followed by cross-linking ICAM-1
for 2 hours for chemokine steady state mRNA and 6 hours
for chemokine secretion. RNA and cell supernatants were
subsequently harvested for RT-PCR and ELISA.
Statistical analysis
Data were analyzed for significance using a one-way anal-
ysis of variance (ANOVA) with Bonferroni post-test cor-
rection for multiple comparisons [25]. Data were
considered significant at p < 0.05. Analysis of relative gene
expression from real time PCR data were analyzed using
the 2-∆∆CT method [19].
Results
Cross-linking ICAM-1 selectively stimulates 
phosphorylation of p42, p44 and JNK MAP kinase in 
airway epithelial cells in vitro
Utilizing western blot analysis, we investigated the effect
of ICAM-1 cross-linking on the phosphorylation of p42/
p44, JNK, and p38 MAP kinase. ICAM-1 cross-linking
selectively stimulated phosphorylation of p42/p44 and
JNK but not p38 in both A549 cells (Fig. 1a) and NHBE
cells (Fig 1b) in vitro. The phosphorylation of p42/ p44
MAP kinase was maximal within 10 minutes after stimu-
lation and gradually returned to baseline 30 minutes after
treatment. The phosphorylation for JNK MAP kinase was
maximal within 30 minutes of treatment. The control
antibodies: (anti-mouse IgG1 and subsequently anti-
mouse IgG F(ab')2) and (anti-VCAM-1 mAb subsequently
incubated with 50 ug/ml anti-mouse IgG F(ab')2), did not
phosphorylate p42/ p44, JNK, or p38 MAP kinase in
either A549 cells or NHBE cells. Interestingly, cells that
were not pre-stimulated with TNFα to increase ICAM-1
surface expression [3], did not phosphorylate p42/ p44
Cross-linking of ICAM-1 induces phosphorylation of MAP  kinases in airway epithelial cells. (Figure A. A549 cells) (Fig- ure B. NHBE cells) Figure 1
Cross-linking of ICAM-1 induces phosphorylation of 
MAP kinases in airway epithelial cells. (Figure A. 
A549 cells) (Figure B. NHBE cells). Lane 1 represents 
cultures that were cross-linked with control IgG1 mAb and 
anti-mouse IgG F(ab')2 for 10 min. Lanes 2–5 represent cul-
tures that were cross-linked with anti-ICAM-1 mAb and anti-
mouse IgG F(ab')2 for 5 min (lane 2), 10 min (lane 3), 15 min 
(lane 4), and 30 min (lane 5). Lane 6 represents cultures 
that were exposed with anti-ICAM-1 mAb alone for 10 min. 
Lane 7 represents cultures that were exposed with anti-
mouse IgG F(ab')2 mAb alone for 10 min. Lane 8 represents 
cultures that were exposed to anti-VCAM-1 mAb and anti-
mouse IgG F(ab')2 for 10 min. Fold increase in amounts of 
phosphorylated MAP kinase proteins as indicated above are 
expressed as the mean ± SD in three different experiments.Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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Selective induction of chemokine mRNA by airway epithelial  cultures cross-linked with ICAM-1. (Figure A. A549 cells)  (Figure B. NHBE cells) Figure 2
Selective induction of chemokine mRNA by airway 
epithelial cultures cross-linked with ICAM-1. (Figure 
A. A549 cells) (Figure B. NHBE cells). Cultures were 
incubated with control IgG1 mAb and anti-mouse IgG F(ab')2 
(white columns) or anti-ICAM-1 mAb and anti-mouse IgG 
F(ab')2 (black columns) for the indicated times before RNA 
was isolated for real time RT-PCR analysis of both RANTES 
and IL-8 message (40 PCR cycles). Messenger RNA of the 
18s ribosomal gene was amplified under the same conditions 
and was used as the internal control. (n = 6; * = significantly 
different from control; p < 0.05).
Cross-linking of ICAM-1 induces selective chemokine secre- tion from airway epithelial cells. (Figure A. A549 cells) (Figure  B. NHBE cells) Figure 3
Cross-linking of ICAM-1 induces selective chemokine 
secretion from airway epithelial cells. (Figure A. 
A549 cells) (Figure B. NHBE cells). Cultures were incu-
bated with control IgG1 mAb and anti-mouse IgG F(ab')2 or 
anti-ICAM-1 mAb and anti-mouse IgG F(ab')2 for the indi-
cated times. Both RANTES and IL-8 was detected in superna-
tants by ELISA.(n = 6; * = significantly different from control; 
p < 0.05).Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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and JNK when treated with antibodies to cross-link ICAM-
1 (data not shown).
Cross-linking ICAM-1 selectively increases chemokine 
mRNA expression in airway epithelial cells in vitro
To investigate the effect of ICAM-1 cross-linking on chem-
okine gene expression, we employed real time RT-PCR.
ICAM-1 cross-linking for 1, 2 and 4 hours stimulated
RANTES gene expression, however, had no effect on IL-8
gene expression in both A549 cells (Fig 2a) and NHBE
cells (Fig 2b) in vitro. Cultures that were not pretreated
with TNFα to increase ICAM-1 surface expression did not
stimulate either chemokine gene expression when treated
with antibodies to cross-link ICAM-1 (data not shown).
Cross-linking ICAM-1 selectively stimulates chemokine 
secretion in airway epithelial cells in vitro
To further investigate the effect of ICAM-1 cross-linking
on both A549 cells and NHBE cells, we utilized an ELISA
to determine the effect of ICAM-1 cross-linking on IL-8
and RANTES secretion. ICAM-1 cross-linking for 1, 2, 4, 6
and 12 hours demonstrated no effect on IL-8 secretion.
However, in contrast to IL-8, cross-linking ICAM-1 stimu-
lated RANTES secretion in both A549 cells (Fig. 3a) and
NHBE cells (Fig 3b) in vitro. Once again, cultures that
were not pretreated with TNFα to increase ICAM-1 surface
expression failed to stimulate chemokine secretion when
treated with antibodies to cross-link ICAM-1 and assayed
by ELISA (data not shown).
ICAM-1 induced RANTES production is mediated by p42/ 
p44 phosphorylation
Because ICAM-1 cross-linking stimulates phosphoryla-
tion of both p42 /p44 and JNK, we investigated the effect
of the ERK inhibitor (PD98059) and a JNK inhibitor (JNK
inhibitor-1) on RANTES regulation. As demonstrated by
western blot analysis, PD98059 inhibited ICAM-1
induced p42/p44 phosphorylation in both A549 cells (Fig
4a.) and NHBE cells (Fig 4b.) in vitro. Additionally, JNK
inhibitor-1 inhibited ICAM-1 induced JNK phosphoryla-
tion in both A549 cells and NHBE cells (Fig 4) in vitro.
When examining the effect of these inhibitors on RANTES
gene regulation, ICAM-1 cross-linking induced RANTES
gene expression was inhibited by the ERK inhibitor
PD98059 in A549 cells (Fig 5a.) and NHBE cells (Fig 5b.),
while JNK inhibitor-1 had no effect on these events (Fig
5). In addition, PD98059 inhibited ICAM-1 induced
RANTES secretion in both cultures and JNK inhibitor-1
had no effect on RANTES secretion in both cultures (Fig
6). Treatment of both cell cultures with PD98059 alone or
JNK inhibitor-1 alone had no effect on chemokine gene
expression or secretion at the doses and times indicated
(data not shown).
Cytotoxicity
None of the inhibitors or solubilization vehicles used in
these studies affected RANTES gene expression, surface
expression, or MAP kinase phosphorylation when added
by themselves or in combination with treatments. In addi-
tion, all experiments were done with non-cytotoxic con-
centrations of TNFα and inhibitors as determined by LDH
assay [26].
Discussion
Intercellular adhesion molecule1 (ICAM-1) is an adhe-
sion molecule that has multiple physiological functions
Inhibition of ICAM-1 cross-linking induced phosphorylation  of MAP kinases in airway epithelial cells (Figure A. A549 cells)  (Figure B. NHBE cells) Figure 4
Inhibition of ICAM-1 cross-linking induced phosphor-
ylation of MAP kinases in airway epithelial cells (Fig-
ure A. A549 cells) (Figure B. NHBE cells). Cultures 
were pre-incubated in the presence of increasing concentra-
tions of MAP kinase inhibitors. Cultures were then cross-
linked for 10 minutes to assess ERK phosphorylation and 30 
minutes to assess JNK phosphorylation. Lane 0 represents 
cultures that were cross-linked with control IgG1 mAb and 
anti-mouse IgG F(ab')2 for 10 minutes for ERK phosphoryla-
tion and 30 minutes for JNK phosphorylation. Lane C rep-
resents a negative protein control prepared from cells 
incubated in media alone. Lane T represents cultures that 
were stimulated with 10 mg/ml TNF for 10 min to serve as a 
positive control. Cultures that were not cross-liked and pre-
incubated with either MAP kinase inhibitor alone had no 
effect on MAP Kinase phosphorylation. Fold increase in 
amounts of phosphorylated ERK and JNK proteins are 
expressed as the mean ± SD in three different experiments.Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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including cell growth, differentiation, and leukocyte traf-
ficking [2]. In the inflammatory process, ICAM-1 serves as
the receptor for the Beta 2 integrin molecule present on
leukocytes, promoting transendothelial migration to sites
of inflammation [27]. In addition to diapedesis, ICAM-1
has been shown to function as a signaling molecule trans-
mitting outside-inside signaling, resulting in multiple bio-
logical effects. Studies have demonstrated that activating
ICAM-1 can induce phosphorylation of intracellular pro-
teins, resulting in activation of both protein kinases and
transcription factors [28-30].
The focus of this study was to determine whether ligation
of ICAM-1 on airway epithelial cells previously exposed to
the cytokine TNFα to increase ICAM-1 surface expression,
resulted in outside-inside signaling. The technique of
using antibodies to cross-link ICAM-1 has been utilized
by numerous investigators attempting to discover the bio-
logical effects of ICAM-1 ligation; this ligation has been
shown to mimic events that occur in vivo [22,31]. Cul-
tures were pretreated with TNFα for two hours, then incu-
bated in medium alone for 18 hours to up-regulate ICAM-
1 surface expression. In these experiments we utilized two
types of cell cultures; a human lung adenocarcinoma cell
line (A549), as representative of distal respiratory epithe-
lium, and primary cultures of normal human bronchial
epithelial (NHBE) cells to serve as a representative of
proximal respiratory epithelium.
Data presented here demonstrates for the first time that
cross-linking ICAM-1 resulted in selective phosphoryla-
tion of MAP kinases in both A549 cells and a fully differ-
entiated primary culture of NHBE cells. Surprisingly,
cultures that were not exposed to TNFα, which express
only basal levels of ICAM-1 on their surface [3] did not
result in phosphorylation of MAP kinases, or an increase
in cytokine gene expression and secretion. One possible
explanation for these findings may be that basal or consti-
tutive levels of ICAM-1 surface expression contain insuffi-
cient numbers of molecules on the cell surface preventing
subsequent ICAM-1 dimerization preventing outside-
inside signaling. Studies investigating HUVEC [32] and
renal fibroblast [33]in vitro demonstrated that basal
expression of ICAM-1 was sufficient to stimulate intracel-
lular signaling. In contrast, cytokine stimulation was
required on cardiomyocytes [22]to successfully alter cellu-
lar events related to cross-linking ICAM-1, suggesting
ICAM-1 signaling events may appear to be dependent on
the cell type or basal expression of ICAM-1. Currently, no
studies have been reported that determine the minimum
ICAM-1 molecules necessary for successful activation of
ICAM-1 on the cell surface or how basal ICAM-1 surface
expression differs between cell types. In these studies,
cross-linking ICAM-1 in both airway cultures stimulated
with TNFα to increase ICAM-1 surface expression,
Selective inhibition of ICAM-1 cross-linking induced RANTES  mRNA in airway epithelial cultures by MAP kinase inhibitors  (Figure A. A549 cells) (Figure B. NHBE cells) Figure 5
Selective inhibition of ICAM-1 cross-linking induced 
RANTES mRNA in airway epithelial cultures by MAP 
kinase inhibitors (Figure A. A549 cells) (Figure B. 
NHBE cells). Cultures were pre-incubated in the presence 
of increasing concentrations of MAP kinase inhibitors and 
subsequently cross-linked for two hours with anti-ICAM-1 
mAb and anti-mouse IgG F(ab')2 before RNA was isolated for 
RT-PCR analysis of RANTES message (40 PCR cycles). Mes-
senger RNA of the 18s ribosomal gene was amplified under 
the same conditions and was used as the internal control. 
Lane 0 represents cultures that were cross-linked with con-
trol IgG1 mAb and anti-mouse IgG F(ab')2 for 2 hours. Cul-
tures pre-incubated with MAP kinase inhibitors alone had no 
effect on RANTES or IL-8 mRNA. (n = 6; * = significantly dif-
ferent from control; † = significantly different from 0.5 µM 
PD98059; p < 0.05).Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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resulted in a selective increase in phosphorylation of ERK
and JNK while having no effect on p38, as detected by
western blot analysis utilizing antibodies directed specifi-
cally to phosphorylated p42/p44, JNK, and p38 in both
cell cultures. Data presented here also demonstrated that
phosphorylation of both ERK and JNK as a result of
ICAM-1 cross-linking was inhibited by the commercially
available MAP kinase inhibitors PD98059 and JNK inhib-
itor-1 respectively. PD98059 is a cell-permeable selective
MAP kinase kinase (MEK) inhibitor that prevents activa-
tion of MAP kinase and subsequent phosphorylation of
MAP kinase substrates. JNK activation was inhibited by a
cell permeable biologically active peptide (JNK inhibitor-
1), which inhibits the phosphorylation of the activation
domains of JNK.
The upstream signaling mechanisms that induce phos-
phorylation and activation of MAP kinases following
ICAM-1 ligation have yet to be determined and appear to
be dependent on the cell type. The cytoplasmic domain of
ICAM-1 is relatively short, contains two tyrosine residues,
but does not contain the motif that has been shown to
mediate Src family kinase, and has no apparent kinase
activity [2]. Despite the lack of the Src motif, ligation of
ICAM-1 on A20 B cell lymphoma cells has been shown to
activate the Src family kinase p53/p56lyn, Raf-1 and MAP
kinase ERK [28]. In addition, cross-linking ICAM-1 on
human pulmonary microvascular endothelial cells
induced activation of SRC tyrosine kinases through an
oxidant dependent pathway that was dependent on xan-
thine oxidase [30]. How ICAM-1 ligation induces activa-
tion of these tyrosine kinases is currently unknown.
However, in preliminary experiments, we have found that
ICAM-1 cross-linking has been shown to stimulate tyro-
sine phosphorylation of several proteins in the airway epi-
thelium (unpublished data).
Since ICAM-1 expression is upregulated in inflammation-
associated lung diseases, and cross-linking ICAM-1 on air-
way epithelial activated ERK and JNK in vitro, we further
investigated whether ICAM-1 cross-linking altered the
expression of the pro-inflammatory chemokines RANTES
and IL-8. As a member of the CC chemokine family of
proteins, RANTES is a potent chemoattractant for eosi-
nophils, basophils, monocytes, and memory T lym-
phocytes. As a member of the CXC chemokine family, IL-
8 is also a potent chemoattractant for neutrophils. Both of
these chemokines have been implicated in a variety of dis-
eases characterized by lung inflammation [10,34,35].
Interestingly, cross-linking ICAM-1 in this study resulted
in an increase in only RANTES gene expression and secre-
tion and not IL-8 from both A549 cells and primary cul-
tures of NHBE cells. Studies in human vascular
endothelial cells (HUVEC) demonstrated that ICAM-1
activation resulted in enhanced RANTES gene expression
Inhibition of ICAM-1 cross-linking induced RANTES secre- tion from airway epithelial cultures by PD98059 (Figure A.  A549 cells) (Figure B. NHBE cells) Figure 6
Inhibition of ICAM-1 cross-linking induced RANTES 
secretion from airway epithelial cultures by PD98059 
(Figure A. A549 cells) (Figure B. NHBE cells). Epithe-
lial cultures were pre-incubated for 30 minutes in the pres-
ence of increasing concentrations of MAP kinase inhibitors. 
Cultures were then incubated with anti-ICAM-1 mAb and 
anti-mouse IgG F(ab')2 for 6 hours. Cultures pre-incubated 
with MAP kinase inhibitors alone had no effect on RANTES 
secretion. (Results represent means ± SD of triplicate meas-
urements). (n = 6; * = significantly different from control; $ = 
significantly different from 0.0 µM PD98059; † = significantly 
different from 0.5 µM PD98059; p < 0.05).Respiratory Research 2006, 7:12 http://respiratory-research.com/content/7/1/12
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and secretion [32], however this study also demonstrated
an increase in IL-8 expression and secretion in HUVEC.
The data presented in these studies investigating these
chemokines demonstrate a different response in the air-
way epithelium. While cross-linking the airway epithe-
lium resulted in an increase in RANTES gene expression
and secretion, it did not increase either IL-8 gene expres-
sion or secretion. Additional studies investigating ICAM-1
cross-linking in human renal fibroblasts also stimulated
RANTES expression, suggesting that the effects of cross-
linking ICAM-1 appears to be cell specific [33]. For exam-
ple, while both HUVEC [32] and renal fibroblasts [33]
grown in culture are capable of stimulating RANTES
expression following ICAM-1 ligation, HUVEC involved
an ERK dependent pathway while renal fibroblasts uti-
lized a calcium dependent, ERK independent signaling
pathway. The upstream events leading to ERK phosphor-
ylation following ICAM-1 cross-linking remains to be elu-
cidated. In results presented here, both RANTES mRNA
and protein secretion, induced by ICAM-1 cross-linking,
were inhibited by PD98059 however unaltered by JNK
inhibitor-1 in both airway epithelial cell cultures when
analyzed with real-time PCR and ELISA respectively. Nei-
ther MAP kinase phosphorylation, RANTES mRNA, or
secretion were induced in airway cultures when exposed
to the following antibodies: an unrelated antibody such as
VCAM-1, a control murine IgG1 antibody, a control
murine IgG1 antibody and anti-mouse IgG(ab')2. These
results demonstrated specificity to ICAM-1 ligation and
not a response due to nonspecific alterations in the cells
surface. Our data also indicates that ICAM-1 cross-linking
stimulates a synergistic increase in TNFα-mediated
RANTES production involving activation of ERK in airway
epithelial cells.
In summary, we have demonstrated that cross-linking
ICAM-1 on the surface of both A549 and NHBE cells selec-
tively induced RANTES gene expression and protein secre-
tion and did not alter either IL-8 gene expression or
secretion. While A549 cells (lower airway) secreted sub-
stantially more RANTES than NHBE cells (upper airway),
both cell types demonstrated that ICAM-1 cross-linking
induced a synergistic increase in TNFα-mediated RANTES
gene expression and protein secretion that is dependent
on activation of MAP kinase p42/p44.
Conclusion
There is increasing evidence demonstrating that intercel-
lular adhesion molecule 1 is up-regulated in inflamma-
tory diseases of the lung. Understanding the role of ICAM-
1 in the lung is essential to understanding the pathogene-
sis of inflammatory airway diseases. The data from this
study demonstrate for the first time that airway epithelial
cells can selectively induce outside-inside signaling
through ICAM-1 ligation. Specifically, cross-linking
ICAM-1 stimulated RANTES gene expression and protein
secretion through an ERK-dependent pathway. These
results suggest that ICAM-1 can function not only as a
receptor for diapedesis of leukocytes, but may also
enhance inflammation in the airway through the secre-
tion of chemokines such as RANTES.
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